Denmark· DK-28106977123
Alprostadil Carefarm
A alprostadil product containing alprostadil, registered in Denmark by Orifarm A/S. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Alprostadil is registered in 10 of 19 countries.
Countries holding a registration under ATC C01EA01 (alprostadil), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Alprostadil · ATC C01EA01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ALPROSTADIL
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- C01EA01
- ATC class
- Alprostadil
- Defined daily dose
- 0.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106977123
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
84 interactions on record for alprostadil.
Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alprostadil · interactions on record
84 records
- 22 moderate
- 62 info
Most severe, free to view
- LorcaserinA08AA11moderate
- DapagliflozinA10BK01moderate
- CanagliflozinA10BK02moderate
- EmpagliflozinA10BK03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01EA01
Alprostadil, as other registers publish it.
- SwitzerlandALPROSTADIL Leman IV 500 mcg/ml, solution à diluer pour perfusionLeman SKL SA
- CzechiaALPROSTANZentiva, k.s., Praha
- FinlandNeupedixOresund Pharma ApS (Øresund Pharma)
- DenmarkNeupedixOresund Pharma ApS
- NetherlandsPropedix 0,5 mg/ml concentraat voor oplossing voor infusieOresund Pharma ApS
- BelgiumPropedix 0.5 mg/mlOresund Pharma
- CzechiaPROSTAVASINAMDIPHARM LIMITED, Dublin
- PolandProstavasin 60Amdipharm Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55ba00e5-c4c0-4b5c-9da7-bd4eccf32a16 GET /v1/drugs/55ba00e5-c4c0-4b5c-9da7-bd4eccf32a16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "0,5 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28106977123",
"substance": "ALPROSTADIL",
"auth_procedure": "Par-Imp",
"in_medicinpriser": false,
"registration_date_serial": "45324"
}See everything about alprostadil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.